Guangdong VTR Bio-Tech Co., Ltd. (SHE:300381)
China · Delayed Price · Currency is CNY 5.57
-0.14 (-2.45%)
Sep 2, 2026, 2:20 PM CST
Guangdong VTR Bio-Tech Revenue
Guangdong VTR Bio-Tech had revenue of 184.18M CNY in the quarter ending June 30, 2026, a decrease of -13.37%. This brings the company's revenue in the last twelve months to 814.07M, down -3.54% year-over-year. In the year 2025, Guangdong VTR Bio-Tech had annual revenue of 832.26M with 0.73% growth.
Revenue (ttm)
814.07M
Revenue Growth
-3.54%
P/S Ratio
3.37
Revenue / Employee
736.05K
Employees
1,106
Market Cap
2.74B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 832.26M | 6.05M | 0.73% |
| Dec 31, 2024 | 826.20M | 30.18M | 3.79% |
| Dec 31, 2023 | 796.02M | -377.98M | -32.20% |
| Jan 1, 2023 | 1.17B | -718.15M | -37.95% |
| Jan 1, 2022 | 1.89B | -22.60M | -1.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Baolingbao Biology | 2.85B |
| Qingdao Vland Biotech INC. | 1.42B |
| Beijing Kawin Technology Share-Holding | 1.23B |
| Landfar Bio-medicine | 660.26M |
| Hubei Goto Biopharm Group | 650.05M |
| Zhejiang Shouxiangu Pharmaceutical | 611.43M |
| Shanghai Model Organisms Center | 432.55M |
| Guanhao Biotech | 361.40M |